Back to search

Netherlands· NL-29bfca4dad17

Pioglitazone Actavis 15 mg tabletten

A pioglitazone product containing pioglitazonhydrochloride, registered in Netherlands by Actavis Group PTC ehf. The same ATC class is registered in 18 of our 19 countries.

ATC A10BG03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPioglitazone Actavis 15 mg tablettenATCA10BG03REGISTER NO.NL-29bfca4dad17PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Pioglitazone is registered in 18 of 19 countries.

Countries holding a registration under ATC A10BG03 (pioglitazone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Pioglitazone · ATC A10BG03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pioglitazone costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.11 in United States to $1.64 in Switzerland — a ×14 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Pioglitazone · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.64
  • ES Spain$1.22
  • IT Italy$0.81
  • US United States$0.11 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PIOGLITAZONHYDROCHLORIDE
Manufacturer
Actavis Group PTC ehf
Country
Netherlands (NL)
ATC code
A10BG03
ATC class
Pioglitazone
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/12/755

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

732 interactions on record for pioglitazone.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pioglitazone · interactions on record

732 records

  • 11 severe
  • 302 moderate
  • 63 minor
  • 355 info

Most severe, free to view

  • ClopidogrelB01AC04severe
  • GemfibrozilC10AB04severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pioglitazone in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pioglitazone products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Bulgaria · Pioglitazone Sanovel, Пизона
  • Cyprus · Zipion
  • Czechia · Novapio, Pioglitazon Viatris
  • Germany · Pioglitazon Aurobindo
  • Spain · Pioglitazona Aurovitas, Pioglitazona Cinfa
  • United Kingdom (Northern Ireland) · Pioglitazone Brown And Burk Uk Ltd, Pioglitazone Generics
  • Greece · Glitact, Raglitan
  • Croatia · Novapio, Pioglitazon Pliva
  • Iceland · Actos, Pioglitazone Accord
  • Italy · Pioglitazone Aurobindo, Pioglitazone Doc Generici
  • Liechtenstein · Actos, Pioglitazone Accord
  • Latvia · Zipion
  • Malta · Novapio
  • Norway · Actos, Pioglitazone Accord
  • Poland · Pioglitazone Bioton
  • Portugal · Pioglitazona Atrolex, Pioglitazona Aurovitas
  • Sweden · Pioglitazone Holsten

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd7784da-e1f2-4098-978e-028e07563f89
GET /v1/drugs/dd7784da-e1f2-4098-978e-028e07563f89?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/pioglitazone-actavis-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Pioglitazone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp108966",
  "excipients": [
    "CARMELLOSE CALCIUM (E 466)",
    "HYPROLOSE (E 463)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)"
  ],
  "substances": [
    "PIOGLITAZONHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2012/03/15",
  "procedure_number": "EMEA/H/C/002324",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/12/755",
  "additional_monitoring": "N"
}

See everything about pioglitazone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.